Management of Hypersensitivity Reactions to Taxanes

被引：62
|
作者：
Picard, Matthieu [1 ]
机构：
[1] Univ Montreal, Hop Maison Neuve Rosemont, Dept Med, Div Allergy & Immunol, 5415 Blvd Assompt, Montreal, PQ H1T 2M4, Canada
来源：
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA | 2017年 / 37卷 / 04期
关键词：
Taxane; Paclitaxel; Docetaxel; Allergy; Hypersensitivity; Skin test; Desensitization and challenge; CUTANEOUS LUPUS-ERYTHEMATOSUS; ALBUMIN-BOUND PACLITAXEL; STEVENS-JOHNSON-SYNDROME; PHASE-II TRIAL; RAPID DESENSITIZATION; NAB-PACLITAXEL; COMPLEMENT ACTIVATION; CROSS-REACTIVITY; FLUID RETENTION; CREMOPHOR-EL;
D O I：
10.1016/j.iac.2017.07.004
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
Taxanes are an important class of antineoplastic agents used in the treatment of a wide variety of cancers. However, paclitaxel and docetaxel, which are the most commonly used taxanes, elicit immediate hypersensitivity reactions (HSRs) in 5% to 10% of patients. Almost all patients that experience these reactions can be safely re-exposed to taxanes either through desensitization or challenge. This article describes the clinical presentation, diagnosis, and management of HSRs to taxanes and discusses the different options for their safe readministration.
引用
收藏
页码：679 / +
页数：16
相关论文
共 50 条
  • [41] Diagnosis and Management of Immediate Hypersensitivity Reactions to Cephalosporins
    Dickson, Scott D.
    Salazar, Kimberly C.
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2013, 45 (01) : 131 - 142
  • [42] Diagnosis and Management of Immediate Hypersensitivity Reactions to Cephalosporins
    Scott D. Dickson
    Kimberly C. Salazar
    Clinical Reviews in Allergy & Immunology, 2013, 45 : 131 - 142
  • [43] Management of hypersensitivity reactions in mucopolysacchariclosis type II
    Miebach, E.
    Schulze-Frenking, G.
    Knoche, K.
    Mengel, E.
    Beck, M.
    ACTA PAEDIATRICA, 2008, 97 : 98 - 98
  • [44] Management of hypersensitivity reactions to iodinated contrast media
    Brockow, K
    Christiansen, C
    Kanny, G
    Clément, O
    Barbaud, A
    Bircher, A
    DeWachter, P
    Guéant, JL
    Guéant, RMR
    Mouton-Faivre, C
    Ring, J
    Romano, A
    Sainte-Laudy, J
    Demoly, P
    Pichler, WJ
    ALLERGY, 2005, 60 (02) : 150 - 158
  • [45] Evaluation and management of hypersensitivity reactions to chemotherapy agents
    Tham, Elizabeth Huiwen
    Cheng, Yew Kuang
    Tay, Miah Hiang
    Alcasabas, Ana Patricia
    Shek, Lynette Pei-Chi
    POSTGRADUATE MEDICAL JOURNAL, 2015, 91 (1073) : 145 - 150
  • [46] Hypersensitivity reactions associated with oxaliplatin and their clinical management
    Toki, Maria I.
    Saif, Muhammad Wasif
    Syrigos, Kostantinos N.
    EXPERT OPINION ON DRUG SAFETY, 2014, 13 (11) : 1545 - 1554
  • [47] Diagnosis and Management of Immediate Hypersensitivity Reactions to Cephalosporins
    Kim, Min-Hye
    Lee, Jong-Myung
    ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2014, 6 (06) : 485 - 495
  • [48] Practical issues in the management of hypersensitivity reactions: Sulfonamides
    Tilles, SA
    SOUTHERN MEDICAL JOURNAL, 2001, 94 (08) : 817 - 824
  • [49] Methotrexate hypersensitivity reactions in pediatrics: Evaluation and management
    Dilley, Meredith A.
    Lee, Joyce P.
    Broyles, Ana Dioun
    PEDIATRIC BLOOD & CANCER, 2017, 64 (05)
  • [50] Omalizumab for management of hypersensitivity reactions to anticancer drugs
    Grover, Piyush
    Krummenacher, Matthew
    Loy, Timothy
    Nowak, Anna K.
    Lucas, Michaela
    INTERNAL MEDICINE JOURNAL, 2024, 54 (08) : 1396 - 1400
12345